Dosidal · Switzerland

Xofluza, Granulat zur Herstellung einer Suspension zum Einnehmen

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:68068 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 68068
atc: J05AX25
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2021-11-19
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: J05AX25
authorisation_number: 68068
form: GRAS
holder: Roche Pharma (Schweiz) AG
holder_partner_nr: 1000726
it_number: 08.03.0.
name: Xofluza, Granulat zur Herstellung einer Suspension zum Einnehmen
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
oKcn4FfgwPUk6f82Sa5QcaK8yaMLE18R3-5499qK4WYxrvROOfjeEKLB4WDrgi3hC3QfLyC6DklyRjNIFq4DYA
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

Dosidal